Literature DB >> 3127463

Isolation and characterization of an expressible cDNA encoding human IL-3. Induction of IL-3 mRNA in human T cell clones.

T Otsuka1, A Miyajima, N Brown, K Otsu, J Abrams, S Saeland, C Caux, R de Waal Malefijt, J de Vries, P Meyerson.   

Abstract

We have isolated cDNA clones encoding human IL-3 from libraries constructed in a modified pcD mammalian expression vector by using mRNA prepared from activated human T cell clones. Amino acid sequence of human IL-3 deduced from DNA sequence of these cDNA clones agrees with that predicted from genomic sequence except at amino acid position 27. Northern blotting analysis and S1 nuclease analysis show that almost all activated T cell clones express IL-3 mRNA with kinetics similar to that observed in mouse T cell clones. However, striking difference was found in the level of granulocyte-macrophage-CSF and IL-3 mRNA expressed in activated human T cells. In contrast to mouse T cell clones, granulocyte-macrophage-CSF mRNA is expressed at least two orders of magnitude more abundant than IL-3 mRNA. Yeast Saccharomyces cerevisiae carrying human IL-3 cDNA fused downstream to alpha-factor leader sequence expressed and secreted biologically active IL-3. Several different rat anti-peptide antisera have been used to confirm the presence of human rIL-3 immunochemically. The immunoreactive human IL-3 expressed in transiently transfected COS7 cells or in yeast was observed to be heterogeneous. Human rIL-3 expressed in COS7 cells has multipotential CSF activity in semisolid cultures of bone marrow cells, and selectively induced the proliferation of My-10+ marrow or cord blood cells in liquid cultures.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127463

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Localization of the interleukin-3 gene to rat chromosome 10 by linkage analyses with a variable number of tandem repeats (VNTR).

Authors:  T Kunieda; E Kobayashi; M Tachibana; H Ikadai; T Imamichi
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.

Authors:  L J Levitt; A Nagler; F Lee; J Abrams; M Shatsky; D Thompson
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

3.  Interleukin 3 activates human blood basophils via high-affinity binding sites.

Authors:  P Valent; J Besemer; M Muhm; O Majdic; K Lechner; P Bettelheim
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA.

Authors:  W S Lai; E Carballo; J R Strum; E A Kennington; R S Phillips; P J Blackshear
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

5.  Positive and negative elements regulate human interleukin 3 expression.

Authors:  B Mathey-Prevot; N C Andrews; H S Murphy; S G Kreissman; D G Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Molecular cloning of a novel human cDNA encoding a zinc finger protein that binds to the interleukin-3 promoter.

Authors:  N Koyano-Nakagawa; J Nishida; D Baldwin; K Arai; T Yokota
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

7.  Specific inhibition of interleukin 3 bioactivity by a monoclonal antibody reactive with hematopoietic progenitor cells.

Authors:  P D Emanuel; S C Peiper; Z Chen; D C Sheng; K S Zuckerman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

Review 8.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

9.  Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3.

Authors:  K Kaushansky; S G Shoemaker; V C Broudy; N L Lin; J V Matous; E M Alderman; J D Aghajanian; P J Szklut; R E VanDyke; M K Pearce
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

10.  Molecular evolution of interleukin-3.

Authors:  H Burger; G Wagemaker; J A Leunissen; L C Dorssers
Journal:  J Mol Evol       Date:  1994-09       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.